Evidence map›Paper›PMID 19812581›Full record

Trial reportJournal of perinatology : official journal of the California Perinatal Association2010

Inhaled nitric oxide in premature infants: effect on tracheal aspirate and plasma nitric oxide metabolites.

M A Posencheg, A J Gow, W E Truog, R A Ballard, A Cnaan, S G Golombek, P L Ballard, NO CLD Investigators

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of perinatology : official journal of the California Perinatal Association, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03576885 (Treatment of Delayed Pulmonary Transition in Extremely Preterm Infants & Bronchopulmonary Dysplasia), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03576885 phase1 / phase2terminatednot on this mapstarted 2019, after this paper: background citation

Treatment of Delayed Pulmonary Transition in Extremely Preterm Infants & Bronchopulmonary Dysplasia

TypeinterventionalSponsorAdventHealthRan2019 to 2023Enrolled32ConditionsPulmonary Hypertension, Bronchopulmonary DysplasiaArmsinhaled nitric oxide, Placebo
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Ancestry and genetic associations with bronchopulmonary dysplasia in preterm infants.American journal of physiology. Lung cellular and molecular physiology · 2018
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

M A PosenchegDepartment of Pediatrics, University of Pennsylvania School of Medicine and The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. michael.posencheg@uphs.upenn.edu
A J Gow
W E Truog
R A Ballard
A Cnaan
S G Golombek
P L Ballard
NO CLD Investigators
Children's Medical Center · USRutgers, The State University of New Jersey · USChildren's Mercy Hospital · USUniversity of California, San Francisco · USUniversity of Pennsylvania · USWestchester Medical Center · US

Funding

ZONA-FREE HAMSTER OVA ASSAY AS AN INDICATOR OF MALE FERTILITYM01RR000425 · NCRR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI WANG, CHRISTINA C. · 1985 to 2011
$74.2M
Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Emily S Barrett · 1988 to 2026
$47.4M
ZIDOVUDINE &LAMIVUDINE &NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFM01RR001271 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KESSLER, DAVID A · 1985 to 2006
$22.7M
Zosuquidar trihydrochloride for acute myeloid leukemia &refractory anemiaM01RR000080 · NCRR · UNIVERSITY HOSPITALS OF CLEVELAND · PI DAVIS, PAMELA B · 1985 to 2007
$22.2M
VIRAL DAMAGE TO BRAIN AND NEUROMUSCULAR SYSTEMM01RR000064 · NCRR · UNIVERSITY OF UTAH · PI SWOBODA, KATHRYN J. · 1985 to 2008
$21.7M
TRANSGENIC MOUSE MODELS OF MENTAL RETARDATIONP30HD026979 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI FALK, MARNI J · 1990 to 2015
$15.3M
ZIDOVUDINE VS 2',3'DIDEHYDRO-3'DEOXYTHYMIDINE IN CHILDRENM01RR000240 · NCRR · CHILDREN'S HOSP OF PHILADELPHIA · PI ALTSCHULER, STEVEN M · 1985 to 2006
$15.3M
TIE 1 &oxygen sensitive pulmonary vascular developmentP50HL056401 · NHLBI · CHILDRENS HOSPITAL OF PHILADELPHIA · PI BALLARD, PHILIP L. · 1996 to 2005
$11.0M
INHALED NO IN PREVENTION OF CHRONIC LUNG DISEASEU01HL062514 · NHLBI · CHILDRENS HOSPITAL OF PHILADELPHIA · PI LORCH, SCOTT A · 2000 to 2004
$7.6M
WATER PRECAUTIONS AND TYMPANOSTOMY TUBESM01RR000084 · NCRR · CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS · PI PERLMUTTER, DAVID H · 1985 to 2006
$5.6M
NO-Modified Biomolecules and Pulmonary SignalingR01HL086621 · NHLBI · RUTGERS, THE STATE UNIV OF N.J. · PI GOW, ANDREW J · 2008 to 2016
$2.8M
Pulmonary Collectins, Hyaluronan and MacrophagesR01HL073896 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SAVANI, RASHMIN C · 2004 to 2008
$1.7M
NCRR NIH HHS M01 RR000064NCRR NIH HHS M01 RR000080NCRR NIH HHS M01 RR000084NCRR NIH HHS M01 RR000240NCRR NIH HHS M01 RR000425NCRR NIH HHS M01 RR00064NCRR NIH HHS M01 RR00080NCRR NIH HHS M01 RR00084NCRR NIH HHS M01 RR001271NCRR NIH HHS M01 RR00240NCRR NIH HHS M01 RR00425NHLBI NIH HHS HL62472NHLBI NIH HHS HL62868NHLBI NIH HHS HL 73896NHLBI NIH HHS HL75930NHLBI NIH HHS P50 HL056401NHLBI NIH HHS P50 HL56401NHLBI NIH HHS R01 HL062472NHLBI NIH HHS R01 HL070560NHLBI NIH HHS R01 HL073896NHLBI NIH HHS R01 HL075930NHLBI NIH HHS R01 HL086621NHLBI NIH HHS R01 HL70560NHLBI NIH HHS U01 HL062514NHLBI NIH HHS U01 HL62514NICHD NIH HHS P30 HD026979NICHD NIH HHS P30 HD26979NIEHS NIH HHS P30 ES005022
6 · The paper itself

Abstract

objectiveInhaled nitric oxide (iNO) is a potential new therapy for prevention of bronchopulmonary dysplasia and brain injury in premature infants. This study examined dose-related effects of iNO on NO metabolites as evidence of NO delivery. STUDY

designA subset of 102 premature infants in the NO CLD trial, receiving 24 days of iNO (20 p.p.m. decreasing to 2 p.p.m.) or placebo, were analyzed. Tracheal aspirate (TA) and plasma samples collected at enrollment and at intervals during study gas were analyzed for NO metabolites.

resultiNO treatment increased NO metabolites in TA at 20 and 10 p.p.m. (1.7- to 2.3-fold vs control) and in plasma at 20, 10, and 5 p.p.m. (1.6- to 2.3-fold). In post hoc analysis, treated infants with lower metabolite levels at entry had an improved clinical outcome.

conclusioniNO causes dose-related increases in NO metabolites in the circulation as well as lung fluid, as evidenced by TA analysis, showing NO delivery to these compartments.

Indexed as

Bronchopulmonary DysplasiaGestational AgeHumansInfant, NewbornInfant, PrematureNitratesNitric OxideNitritesRespiratory TherapyTracheaNitratesNitric OxideNitrites

Identifiers

PMID19812581
PMCPMC2834364
OpenAlexW2006760288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.